Carol Cass

WikiDoc Resources for Carol Cass
Articles
Most recent articles on Carol Cass Most cited articles on Carol Cass Review articles on Carol Cass Articles on Carol Cass in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Carol Cass Images of Carol Cass Photos of Carol Cass Podcasts & MP3s on Carol Cass Videos on Carol Cass
Evidence Based Medicine
Cochrane Collaboration on Carol Cass Bandolier on Carol Cass TRIP on Carol Cass
Clinical Trials
Ongoing Trials on Carol Cass at Clinical Trials.gov Trial results on Carol Cass Clinical Trials on Carol Cass at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Carol Cass NICE Guidance on Carol Cass NHS PRODIGY Guidance FDA on Carol Cass CDC on Carol Cass
Books
Books on Carol Cass
News
Carol Cass in the news Be alerted to news on Carol Cass News trends on Carol Cass
Commentary
Blogs on Carol Cass
Definitions
Definitions of Carol Cass
Patient Resources / Community
Patient resources on Carol Cass Discussion groups on Carol Cass Patient Handouts on Carol Cass Directions to Hospitals Treating Carol Cass Risk calculators and risk factors for Carol Cass
Healthcare Provider Resources
Symptoms of Carol Cass Causes & Risk Factors for Carol Cass Diagnostic studies for Carol Cass Treatment of Carol Cass
Continuing Medical Education (CME)
CME Programs on Carol Cass
International
Carol Cass en Espanol Carol Cass en Francais
Business
Carol Cass in the Marketplace Patents on Carol Cass
Experimental / Informatics
List of terms related to Carol Cass

Overview

Carol Cass is an Canadian research scientist. She is internationally recognized as an expert on nucleosides, an important class of anti-cancer drugs. Her research has led to the more effective use of nucleoside drugs and the development of new treatments for patients with acute and chronic leukemias, lymphomas, and cancers of the lung, bladder, breast and pancreas.

She determined that nucleoside-based drugs are able to cross cell membranes by binding to specialized transporter proteins. The drugs are able to enter and directly attack cancer cells during the binding process.

Since 2003, Cass has been director of Alberta’s Cross Cancer Institute. She is Canada research chair in oncology at the University of Alberta.

Awards

• 2006, awarded the Robert L. Noble Prize by the National Cancer Institute of Canada for her contributions to cancer research.

External links

• Robert L. Noble Prize